Popular Articles

New Data From Satraplatin Phase 3 Trial In Second-Line Castrate-Refractory Prostate Cancer Presented At 2009 ASCO Annual Meeting
GPC Biotech AG (FRANKFURT: GPC) (XETRA: GPC) announced that data from the double- blind, randomized satraplatin Phase 3 trial, the SPARC trial (Satraplatin and Prednisone Against Refractory Cancer), were presented at the 2009 American Society for Clinical Oncology (ASCO) Annual Meeting in Orlando, Florida. The SPARC trial evaluated satraplatin plus prednisone versus placebo plus prednisone in 950 patients with castrate-refractory prostate cancer (CRPC) who had progressed after initial chemotherapy. The data presented are retrospective analyses of the SPARC trial evaluating correlations between overall survival (OS) and pain at baseline, pain progression, and progression-free survival (PFS) at three months.
generic viagra online
St. Jude Medical Completes Implants In U.S. Study Of Deep Brain Stimulation For Parkinson's Disease
St. Jude Medical, Inc. (NYSE:STJ) announced the completion of patient implants in its U.S. pivotal clinical study of deep brain stimulation (DBS) for the symptomatic treatment of Parkinson"s disease, a neurological disorder affecting approximately 6.3 million people worldwide that progressively diminishes a person"s control over his or her movements. The announcement was made at the Movement Disorder Society"s 13th International Congress of Parkinson"s Disease and Movement Disorders in Paris.
News of the day
XClinical To Present End-to-End Clinical Process
XClinical, a European vendor of innovative software products for eClinical trials, is presenting CDISC based tools for an End-To-End clinical process at the 45th DIA Annual Meeting in San Diego, USA.
Endocrinology

Risk Of Complications In Pregnancy Increased By Obesity, Study Shows

Expectant mothers who are obese are much more likely to suffer from minor complications such as heart burn and chest infections during pregnancy, a study suggests. Research by the University of Edinburgh found that obese mothers-to-be were nearly 10 times more likely to suffer from chest infections, and more than twice as likely to suffer from headaches and heartburn, compared with pregnant women of a healthy weight. Researchers studied the records of more than 650 pregnant women, of whom nearly half were overweight or obese at the beginning of their pregnancy. The study took into account factors such as age and smoking. Obese pregnant women were three times more likely to have carpal tunnel syndrome, which occurs when an increase in fluid causes swelling in the wrist. The condition can lead to tingling, pain, numbness and lack of coordination in the hands. The study, published in the British Journal of Obstetrics and Gynaecology, also found that obese women had a more than three-fold increased risk of suffering from a condition known as symphysis-pubis dysfunction, which affects the pelvic joints and may cause walking difficulties if severe. The costs of treating minor complications in obese women were estimated to be more than three times that of treating women of a healthy body weight. Dr Rebecca Reynolds, of the Tommy"s Centre for Maternal and Fetal Health at the University of Edinburgh: "Although symptoms such as heartburn are common and generally perceived to be benign, they can still have a major impact on the quality of life for pregnant women and can be linked to more serious conditions. What may be termed as minor complications can make a pregnancy much more uncomfortable and are also associated with higher treatment costs." Around a quarter of pregnant women giving birth are obese. The Tommy"s Centre for Maternal and Fetal Health at the University of Edinburgh is investigating the implications of obesity in pregnancy and how this can be addressed to improve both the health of mother and child. Obesity during pregnancy also increases the risk of more serious conditions such as gestational diabetes, pre-eclampsia and the need for a caesarean section. More than one-third of pregnancy-related deaths occur in mothers who are obese. Tara Womersley University of Edinburgh


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):